Genital microbiota of women using a 90 day tenofovir or tenofovir and levonorgestrel intravaginal ring in a placebo controlled randomized safety trial in Kenya

In a phase-IIa trial, we investigated the influence of 90 days continuous-delivery tenofovir (TFV) intravaginal rings (IVRs) with/without levonorgestrel (LNG) on the genital microbiota of Kenyan women. Eligible women (n = 27; 18–34 years; negative for HIV, sexually transmitted infections, and Amsel-...

Descripción completa

Detalles Bibliográficos
Autores principales: Dabee, Smritee, Mugo, Nelly, Mudhune, Victor, McLellan-Lemal, Eleanor, Peacock, Sue, O’Connor, Siobhan, Njoroge, Betty, Nyagol, Beatrice, Thurman, Andrea R., Ouma, Eunice, Ridzon, Renee, Wiener, Jeffrey, Haugen, Harald S., Gasper, Melanie, Feng, Colin, Allen, Shannon A., Doncel, Gustavo F., Jaspan, Heather B., Heffron, Renee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9283538/
https://www.ncbi.nlm.nih.gov/pubmed/35835755
http://dx.doi.org/10.1038/s41598-022-13475-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9283538/
https://www.ncbi.nlm.nih.gov/pubmed/35835755
http://dx.doi.org/10.1038/s41598-022-13475-9

Ejemplares similares